These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8905249)

  • 1. How important is 24-hour control of blood pressure?
    Morgan T; Anderson A
    Drug Saf; 1996 Oct; 15(4):243-8. PubMed ID: 8905249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical relevance of the 24-hour trough: peak ratio of antihypertensive drugs.
    Zannad F
    J Hypertens Suppl; 1995 Aug; 13(2):S109-12. PubMed ID: 8576780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of once-daily antihypertensive therapy.
    Myers MG
    Heart Dis; 2000; 2(2):S7-12. PubMed ID: 11728257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adequate blood pressure control: perception and reality.
    Morgan T
    Eur Heart J; 1997 Nov; 18 Suppl E():E9-13. PubMed ID: 9402466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of trough to peak efficacy in the evaluation of antihypertensive therapy.
    Meredith PA
    J Hypertens Suppl; 1998 Jan; 16(1):S59-64. PubMed ID: 9534099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems in the evaluation of antihypertensive therapy using the trough/peak ratio.
    Prattichizzo FA; Galetta F; Simonetti I
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):459-63. PubMed ID: 9310274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
    Sica D; Frishman WH; Manowitz N
    Heart Dis; 2003; 5(3):176-81. PubMed ID: 12783630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The trough/peak ratio].
    Salvetti A; Virdis A
    Ann Ital Med Int; 1995 Oct; 10 Suppl():91S-95S. PubMed ID: 8562276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four-hour ambulatory blood pressure evaluation of antihypertensive agents.
    Zanchetti A
    J Hypertens Suppl; 1997 Dec; 15(7):S21-5. PubMed ID: 9532517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Problems in evaluating the long-term effect of antihypertensive drugs: once again: the trough/peak ratio].
    Hitzenberger G
    Wien Med Wochenschr; 1997; 147(14):333-5. PubMed ID: 9381727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive treatment and trough: peak ratio: general considerations.
    Meredith PA; Elliott HL
    J Hypertens Suppl; 1994 Nov; 12(8):S79-82; discussion S83. PubMed ID: 7707161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trough:peak ratio of the blood pressure response to beta-blockers.
    Wing LM
    J Hypertens Suppl; 1994 Nov; 12(8):S85-90. PubMed ID: 7707162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The rationale for drug combinations in the therapy of arterial hypertension].
    Salvetti A; Virdis A; Di Venanzio L
    Ann Ital Med Int; 1993 Oct; 8 Suppl():107S-110S. PubMed ID: 8117517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration-effect relationships and implications for trough-to-peak ratio.
    Meredith PA; Elliott HL
    Am J Hypertens; 1996 Oct; 9(10 Pt 2):66S-70S; discussion 87S-90S. PubMed ID: 8896666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New FDA guidelines on the treatment of hypertension: comparison of different therapeutic classes according to trough/peak blood pressure responses.
    Meredith PA
    Arch Mal Coeur Vaiss; 1994 Nov; 87(11):1423-9. PubMed ID: 7771888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-measurement of blood pressure at home to evaluate drug effects by the trough: peak ratio.
    Ménard J; Chatellier G; Day M; Vaur L
    J Hypertens Suppl; 1994 Nov; 12(8):S21-5. PubMed ID: 7707151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH; Matzek KM; Kempthorne-Rawson J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug Administration.
    Meredith PA; Elliott HL
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S26-30. PubMed ID: 7609502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension strategies for therapeutic intervention and prevention of end-organ damage.
    Houston MC
    Prim Care; 1991 Sep; 18(3):713-53. PubMed ID: 1946795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.